Doctor profile · Federal record

Dr. Anton Melnyk, MD,FACP

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Abilene, TX

  • NPI 1801834544
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 38 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1100 N 19Th St, Suite 1A
Abilene, TX 796012344
(325) 672-4368
fax (325) 672-3108
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
March 10, 2010
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #J8058
Medicaid (3)
TX #046352301 · TX #117946701 · TX #117946702

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801834544. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
193,993
Distinct HCPCS
10
Medicare allowed
$1,778,603
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 89,250 92 $0
J9271 Injection, pembrolizumab, 1 mg 17,700 21 $54
J9263 Injection, oxaliplatin, 0.5 mg 16,800 12 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 14,847 21 $3
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 14,200 113 $0
J1756 Injection, iron sucrose, 1 mg 10,100 18 $0
J9267 Injection, paclitaxel, 1 mg 7,958 18 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,776 84 $0
J1626 Injection, granisetron hydrochloride, 100 mcg 1,570 38 $0
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 1,560 11 $27

In context: peer comparison

Among 3 peers in this city , average services per provider: 1,523. This provider delivers 127× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,756
Transactions
20
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Gilead Sciences, Inc. 7 $3,678.45
Amgen Inc. 1 $113.63
GENZYME CORPORATION 1 $112.20
Daiichi Sankyo Inc. 1 $104.75
Janssen Scientific Affairs, LLC 1 $102.17
Lilly USA, LLC 1 $99.05
Merck Sharp & Dohme LLC 1 $97.20
Genmab U.S., Inc. 1 $95.26
E.R. Squibb & Sons, L.L.C. 1 $86.84
GlaxoSmithKline, LLC. 1 $79.87
Dendreon Pharmaceuticals LLC 1 $78.55
AstraZeneca Pharmaceuticals LP 1 $72.22
Karyopharm Therapeutics Inc. 1 $21.25
BeiGene USA, Inc. 1 $14.62

By nature of payment

Consulting Fee
$2,850
Food and Beverage
$1,366
Travel and Lodging
$540

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,098
Patients
264
Total drug cost
$540,810
Drug Type Claims Patients Total cost
Anastrozole Generic 331 80 $8,330
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 131 41 $5,828
Ondansetron Hcl Generic 100 52 $907
Prednisone Generic 83 18 $1,204
Potassium Chloride Generic 68 18 $1,275
Tamoxifen Citrate Generic 51 14 $2,429
Fentanyl Generic 47 11 $6,501
Eliquis (Apixaban) Brand 40 0 $27,271
Exemestane Generic 40 0 $4,691
Dexamethasone Generic 38 14 $705

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Anton Melnyk's medical specialty?
Dr. Anton Melnyk practices Hematology & Oncology Physician in Abilene, TX.
Where does Dr. Anton Melnyk practice?
Dr. Anton Melnyk practices at 1100 N 19Th St, Abilene, TX 796012344. Office phone: 3256724368.
What is Dr. Anton Melnyk's NPI?
Dr. Anton Melnyk's National Provider Identifier (NPI) is 1801834544, issued by NPPES.
Does Dr. Anton Melnyk accept Medicare assignment?
Yes. Dr. Anton Melnyk accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Anton Melnyk commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.